Neoplasia I Introduction Husni Maqboul, M.D. Terminology Tumor : Pathologic disturbance of growth, characterized by excessive and unnecessary proliferation.

Slides:



Advertisements
Similar presentations
Neoplasia II: Tumor Characteristics
Advertisements

Leicester Warwick Medical School Neoplasia 1 What is a Tumour? Professor Rosemary A Walker Department of Pathology.
Chapter 5 Neoplasia.
Neoplasia 1: Introduction. terminology oncology: the study of tumors neoplasia: new growth (indicates autonomy with a loss of response to growth controls)
Neoplasia.
Dr. Bruce F. Burns Anatomical Pathology Ottawa Hospital
Introduction to Neoplasia
Pathophysiology - Borders - Spring 2012
Evolution of Neoplasia The Uterine Cervix As a Model Raj C. Dash, MD Duke University Medical Center Durham, North Carolina.
Abdulmalik Alsheikh, M.D, FRCPC Dr. Maha Arafah, MBBS, KSFP
Neoplasia Lecture 1 Definition and Nomenculature Dr. Maha Arafah
Epidemiology 242: Pathology Basis of Caner Jian-Yu Rao, MD Professor of Pathology and Epidemiology Fall, 2009.
Neoplasia Dr. Raid Jastania. Neoplasia: Terminology Cancer is the 2 nd cause of death in the US Neoplasia is “new growth” Neoplasm is an abnormal mass.
Weeks 6 and 7 Neoplasia Dr.İ.Taci Cangül Bursa-2008.
Neoplasia Lecture 2 Dr. Maha Arafah.
Genomics Lecture 7 By Ms. Shumaila Azam. Tumor Tumor – abnormal proliferation of cells that results from uncontrolled, abnormal cell division A tumor.
Pathology of Neoplasia. Neoplasia Shashi-Aug-15 Introduction:  Inflammatory, Degenerative & Neoplastic  Growth – Increase in size due to synthesis of.
Neoplasia. Oncology defined Branch of medicine that deals with the study, detection, treatment and management of cancer and neoplasia.
Neoplasia I Walter C. Bell, M.D..
Abdulmalik Alsheikh, MD, FRCPC
Terminology of Neoplasms and Tumors  Neoplasm - new growth  Tumor - swelling or neoplasm  Leukemia - malignant disease of bone marrow  Hematoma -
NEOPLASIA Nadia Ismiil, MD, FRCPC.
Introduction to Cancer
Principles of Surgical Oncology Salah R. Elfaqih.
Principles of Surgical Oncology Salah R. Elfaqih.
Metastatic Cancer – Gross Pathology Lymph node - metastasis from breastLiver – metastasis from lung Vertebral column – metastasis from prostate Mesentery.
Systemic Pathology. Neoplasia -Abnormal cell growth.
Notes by Dr Sanjay A Pai. Neoplasm An abnormal proliferation of cells, resulting in a mass called a neoplasm.
Abdulmalik Alsheikh, MD, FRCPC
Neoplasia Lecture 1 Dr. Maha Arafah. Neoplasia Upon completion of these lectures, the student should: Define a neoplasm. Contrast neoplastic growth with.
Abdulmalik Alsheikh, MD, FRCPC Maha Arafah, MBBS, KSFP
Principles of Surgical Oncology Done by : 428 surgery team surgery team.
General Pathology Basic Principles of Cellular and Organ Pathology Oncology - II Jaroslava Dušková Inst. Pathol.,1st Med. Faculty, Charles Univ. Prague.
Path 822: Experimental Cancer Diagnostics & Therapeutics: PATHOLOGY OF TUMOURS Sandip SenGupta, M.D. Professor of Pathology September 2005.
Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.
TUMORS and NEOPLASM.
CANCER HCT !. OBJECTIVES  Define and understand the difference between benign and malignant tumors  Students will be able to identify the classifications.
Classification of Tumors
Cytopathology. 7 Dr. Maha Al-Sedik 2015 CLS Neoplasm. 2- Stages of carcinoma. 3- Differences between benign and malignant neoplasm. 4- Dysplasia.
Neoplasia 1. a) Definition b) Terminologies Neoplasia “new growth” Definition: “an abnormal growth of tissue, the growth of which exceed and is uncoordinated.
NEOPLASIA Def.: persistent abnormal
Neoplasia Lecture 2 Maha Arafah,MD,KSFP Abdulmalik Alsheikh, MD, FRCPC CHARACTERISTICS OF BENIGN AND MALIGNANT NEOPLASMS EPIDEMIOLOGY CHARACTERISTICS OF.
Principles of Surgical Oncology
Neoplasia Lecture 1 Maha Arafa,MD,KSFP Abdulmalik Alsheikh, MD, FRCPC.
Neoplasia Lecture 2 Abdulmalik Alsheikh, MD, FRCPC Maha Arafah, MBBS, KSFP Abdulmalik Alsheikh, MD, FRCPC Maha Arafah, MBBS, KSFP CHARACTERISTICS OF BENIGN.
Lecture # 42 NEOPLASIA - 3 Dr
Dr. Osama I Nassif. MD, FRCPC. Associate professor & consultant pathologist. Pathology Dept. King Abdulaziz University. NEOPLASIA بسم الله الرحمن الرحيم.
N EOPLASIA 1 D R. HIBA AL ZOU ’ BI. - Neoplasia literally means "new growth“ - In medicine it is referred to as a tumor, - The study of tumors is called.
Malignant Epithelial Tumors
Neoplasia Lecture 1 Abdulmalik Alsheikh, M.D, FRCPC Dr. Maha Arafah, MBBS, KSFP Foundation block 2013 Pathology Foundation block 2013 Pathology Definition.
General Pathology Basic Principles of Cellular and Organ Pathology Oncology - II Jaroslava Dušková Inst. Pathol.,1st Med. Faculty, Charles Univ. Prague.
Neoplasia I: Tumor Nomenclature
Oral squamous cell carcinoma. A malignancy of epithelial cells Oral and oropharyngeal SCC represent about 3% of cancers in men and 2% of cancers in women.
NEOPLASIA Dr. Manal Maher Hussein.
Neoplasia Basics, Grading and Staging Kimiko Suzue MD, Ph.D. Department of Pathology Mt. Sinai Hospital.
Benign v. Malignant Vocabulary Neoplasm – a new and abnormal growth of tissue in some part of the body Benign – refers to a condition, tumor, or growth.
Neoplasia By Prof.Dr. Ahmed Mohy El Din Intended Learning Outcomes (ILOs): Define neoplasia: Differentiate neoplastic from non neoplastic lesions. Classify.
Unit 7 Neoplasia Neoplasm is an abnormal mass of tissue as a result of neoplasia Neoplasia (new growth in Greek) is the abnormal proliferation of cells.
Chapter 7 Neoplasia.
Nomenclature & Characteristics of Tumours Neoplasia 1
CHARACTERISTICS OF BENIGN AND MALIGNANT TUMORS
Chapter 5 Tumor , neoplasm Department of pathology.
Principles of Surgical Oncology
CLASSIFICATION OF TUMORS
Classification of Tumors
Chapter 3 Neoplasms 1.
Abdulmalik Alsheikh, MD, FRCPC
Cytopathology-8 DR. MAHA AL-SEDIK.
Presentation transcript:

Neoplasia I Introduction Husni Maqboul, M.D.

Terminology Tumor : Pathologic disturbance of growth, characterized by excessive and unnecessary proliferation of cells Galen ( AD ) –Swelling according to nature ( pregnancy ) –Swelling exceeding nature ( Callus ) –Swelling contrary to nature

Terminology Hamartoma : Excessive but focal overgrowth of cells and tissues native to the organ in which it occurs. Cellular elements are mature, but do not produce normal architecture –Hamartroma of lung –Angiomas –Pigmented nevi

Terminology Choristoma (Heterotopia) : Normal cells or tissues, that are present in abnormal locations –Pancreatic cells in the wall of stomach or intestine –Nests of adrenal cells in kidney, lung or ovaries

Terminology Neoplasms : Persistent, abnormal and relatively autonomous proliferation of cells occurring as a result of permanent cellular defect that is passed to the progeny. Usually develops due to a factor(s), but once developed, becomes independent of them.

Types of neoplasms Neoplasms –Parenchyma made up of neoplastic cells –Supporting host derived stroma Benign: localized and amenable to surgical removal; patient usually survives Malignant: invasive tumor capable of destroying structures and spread to distant sites (metastasis); may result in early death of the patient

Examples of benign tumors Epithelial –Adenoma: benign glandular tumor –Papilloma : benign surface epithelial tumors –Polyp : benign tumor projecting over mucosal surface –Cystadenoma : benign epithelial tumor forming hollow cystic mass

Examples of benign tumors Mesenchymal –Chondroma: benign cartilaginous tumor –Leiomyoma: benign smooth muscle tumor –lipoma: benign tumor of fat –Fibroma: benign tumor of fibrous tissue Mixed –Benign Mixed Tumor –divergent differentiation of stem cell (pleomorphic adenoma) –Fibroadenoma – neoplastic fibrous component More than one germ cell layer –Benign teratoma – mature components

leiomyomas

adenoma

Examples of malignant tumors Sarcoma (mesenchymal derivation: fibrosarcoma, chondrosarcoma) Carcinoma (epithelial derivation: adenocarcinoma, squamous cell carcinoma) –Squamous –Adeno –Transitional Lymphoma/leukemia

adenocarcinoma

carcinoma

The terms “benign” and “malignant” describe the biologic behavior of a tumor The biologic behavior is characterized by degree of differentiation of the tumor, rate of growth (and rate of cell death), infiltration of surrounding tissue, and dissemination to distant sites

Differentiation Well-differentiated tumors contain cells that resemble the normal cells of origin Poorly-differentiated or undifferentiated tumors contain cells that do not resemble their normal counterparts (ancillary studies may be needed to determine the cell of origin)

well-differentiated

poorly-differentiated

Benign tumors are composed of well- differentiated cells. Malignant tumors are characterized by a wide range of cellular differentiation. Anaplasia (cellular pleomorphism, hyperchromatic nuclei, high N:C ratio, giant cells, bizarre nuclei) is a feature of malignant tumors. Differentiation

anaplasia

Dysplasia denotes a loss of architectural organization and a loss of cell uniformity in epithelium pleomorphism and mitoses are more prominent than in the normal usually graded: mild, moderate, severe, and carcinoma-in-situ mild to moderate dysplasia is potentially reversible

normal epithelium

dysplasia

Dysplasia Dysplasia is a non-neoplastic proliferation. Dysplasia may or may not progress to cancer.

Rate of growth In general, benign and well-differentiated malignant tumors have a slower rate of growth than moderately-differentiated and poorly-differentiated malignant tumors. There are exceptions. Blood supply, site, and hormonal stimulation are factors that can affect the growth rate of tumors.

Invasion Benign tumors usually grow by slow expansion. Malignant tumors usually infiltrate and may destroy surrounding tissue (cell surface and the extracellular matrix play an important role).

Functional characteristics Benign tumors are more likely to function Epithelial tumors can produce mucin Hormonal production can be unregulated Inappropriate production of hormones by different type of cells Abnormal receptor and antigenic expression

Metastasis indicates malignancy a discontinuous spread of the tumor Methods of metastasis include: (1)seeding of body cavities, (2) lymphatic spread, and (3) hematogenous spread.

metastatic ovarian carcinoma

MRI: metastatic adenocarcinoma

metastatic adenocarcinoma

Grading and staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based on clinical, radiological, and surgical criteria, such as, tumor size, involvement of regional lymph nodes, and presence of metastases. Staging usually has more prognostic value.

Morbidity and mortality metastases rupture into major vessels compression of vital organs organ failure infection

meningioma

basal cell carcinoma

melanoma

Diagnostic procedures FNA (fine needle aspiration) Cytological smears Biopsy Frozen sections Biochemical assays Molecular diagnosis Flow cytometry

cytology smear: adenocarcinoma

Pap smear with dysplasia

frozen section

staining a frozen section

Ancillary studies Immunohistochemistry Cytogenetics Flow cytometry Electron microscopy

cytokeratin stain on a carcinoma

AFP stain on a yolk sac tumor

EM: neurosecretory granules

EM: microvilli, tight junction in an adenocarcinoma

Biochemical assays Tumor markers: sometimes diagnostic or prognostic Can be helpful in monitoring effectiveness of therapy or in detecting relapses/recurrences

Summary Neoplasia- an abnormal mass of tissue which has lost its responsiveness to growth controls Benign neoplasms tend to be slow-growing, well-differentiated tumors which lack the ability to metastasize Benign neoplasms, in general, remain localized and are amenable to surgery

Summary Malignant neoplasms tend to be fast- growing lesions which invade normal structures Malignant neoplasms vary in the degree of differentiation and some show anaplasia Malignant neoplasms are capable of metastasis

Summary The prognosis of a patient with any type of neoplasm depends on a number of factors including: the rate of growth of the tumor, the size of the tumor, the tumor site, the cell type and degree of differentiation, the presence of metastasis, responsiveness to therapy, and the general health of the patient.